Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RGNOSIS: Ecological Effects of Decolonisation Strategies in Intensive Care
2012-002604-41Phase 4Active
- Sponsor
- University Medical Center Utrecht
- Start
- Mar 2014
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of colistin, tobramycin, nystatin, chlorhexidine in multidrug-resistant gram-negative bacilli colonization, bacteremia due to multidrug-resistant gram-negative bacteria, sponsored by University Medical Center Utrecht. Started Mar 2014; status: active.
02
Drugs
colistintobramycinnystatinchlorhexidine
03
Conditions
multidrug-resistant gram-negative bacilli colonizationbacteremia due to multidrug-resistant gram-negative bacteria
Beyond the preview
Go deeper on 2012-002604-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002604-41.